Client News
Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European Biotech investors
22nd February 2023
Esperas Pharma, Inc. announces investment from TVM Life Science Innovation I and the Fonds de solidarité FTQ
21st February 2023
Mainz Biomed acquires entire intellectual property portfolio for its colorectal cancer diagnostic test program
21st February 2023
Leading fashion company joins fiber-to-fiber consortium founded by Carbios, On, Patagonia, PUMA and Salomon
18th February 2023
Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros
16th February 2023
Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
16th February 2023
Mainz Biomed expands european commercial footprint and enters markets in Spain and UK
15th February 2023
Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
14th February 2023
Andera Partners portfolio company Mineralys Therapeutics successfully completes upsized $192 million Nasdaq IPO
14th February 2023
There is no more content to load